Levi & Korsinsky Urges Shareholders: Meet the Lead Plaintiff Deadline in This Ongoing Business Case

Regeneron Pharmaceuticals, Inc. (REGN) Investors: Understanding Your Potential Recovery Options under Federal Securities Laws If you are an investor in Regeneron Pharmaceuticals, Inc. (REGN) and have suffered financial losses as a result of alleged securities fraud, you may be entitled to recover your losses. This blog post aims to provide you with essential information about…

Read More

Grosvenor Corporation (GCM): Analyzing Q4 Earnings – Key Metrics Compared to Estimates

Analyzing GCM Grosvenor’s Q4 2024 Performance: A Comparison with Wall Street Estimates and Year-Ago Numbers GCM Grosvenor (GCMG), a leading global alternative asset management solutions provider, recently released its financial results for the quarter ended December 2024. While the reported revenue and earnings per share (EPS) offer valuable insights into the company’s performance during this…

Read More

Kingsway’s Investor Day at the New York Stock Exchange: Insights and Opportunities on Monday

Kingsway Financial Services Inc. to Host Investor Day after Annual General Meeting Chicago, IL – March 3, 2025 – Kingsway Financial Services Inc. (NYSE: KFS) (“Kingsway” or the “Company”), a leading provider of specialty insurance and reinsurance solutions, is pleased to announce that it will be hosting an Investor Day following the Annual General Meeting…

Read More

Centene Corporation’s Q4 Earnings: A Detailed Analysis of Key Metrics and Their Comparison to Wall Street Estimates

Centene’s Q4 2024 Earnings: A Closer Look Centene Corporation (CNC), a leading health solutions company, recently reported its financial results for the fourth quarter of 2024. While the revenue and Earnings Per Share (EPS) figures offer valuable insights into the company’s performance during this period, it’s essential to examine how these metrics compare with Wall…

Read More